Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
IRONWOOD PHARMACEUTICALS INC has filed 1,401 SEC EDGAR filings since 26 Sep 2008

SEC filing history

Showing 151-175 of 194 matching filings.

Per page
25
Current page
7
8-K File 001-34620

8-K

Filing date
26 Nov 2013
Reporting date
26 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
22 Oct 2013
Reporting date
22 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
23 Jul 2013
Reporting date
23 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
12 Jun 2013
Reporting date
11 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
05 Jun 2013
Reporting date
04 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
24 May 2013
Reporting date
21 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
20 May 2013
Reporting date
20 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
23 Apr 2013
Reporting date
23 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
05 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
15 Jan 2013
Reporting date
15 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
08 Jan 2013
Reporting date
04 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
31 Oct 2012
Reporting date
30 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
29 Oct 2012
Reporting date
23 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
16 Oct 2012
Reporting date
16 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
31 Aug 2012
Reporting date
30 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
18 Jul 2012
Reporting date
17 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
01 Jun 2012
Reporting date
31 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
01 May 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
24 Apr 2012
Reporting date
19 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
28 Feb 2012
Reporting date
28 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
15 Feb 2012
Reporting date
09 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
09 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
08 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
04 Jan 2012
Reporting date
29 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34620

8-K

Filing date
07 Nov 2011
Reporting date
07 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .